William Ackman (L), chief executive of Pershing Square Capital, speaks with David Weinreb, CEO of Howard Hughes Corp. on the floor of the New York Stock Exchangein New York, U.S. on November 10, 2015. REUTERS/Brendan McDermid
Your feedback is important to us!
We invite all our readers to share with us their views and comments about this article.
Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.
Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)
Billionaire investor William Ackman walked away from Valeant Pharmaceuticals International Inc. Monday with a loss of more than $3 billion as he sold his entire stake in the struggling drug company after trying to rescue it for some 18 months.Ackman's Pershing Square Capital Management became one of Valeant's biggest investors in 2015 when it sunk some $3.2 billion into the company.Ackman's fund bought into Valeant when the stock was trading near $190 a share and he watched it surge to $260 before it sharply tumbled after August 2015 .
FOLLOW THIS ARTICLE